Compare · HDSN vs SNN
HDSN vs SNN
Side-by-side comparison of Hudson Technologies Inc. (HDSN) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- HDSN operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $11.67B, about 54.8x HDSN ($213.0M).
- Over the past year, HDSN is down 44.5% and SNN is down 19.1% - SNN leads by 25.5 points.
- SNN has been more active in the news (11 items in the past 4 weeks vs 3 for HDSN).
- SNN has more recent analyst coverage (25 ratings vs 11 for HDSN).
- Company
- Hudson Technologies Inc.
- Smith & Nephew SNATS Inc.
- Price
- $4.99-1.19%
- $28.96-0.41%
- Market cap
- $213.0M
- $11.67B
- 1M return
- -3.11%
- +4.21%
- 1Y return
- -44.55%
- -19.08%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 11
- Recent ratings
- 11
- 25
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest HDSN
- Hudson Technologies to Host Conference Call to Discuss Third Quarter 2026 Results
- Large owner Hartree Partners, Lp bought $604,446 worth of shares (118,549 units at $5.10), increasing direct ownership by 2% to 5,348,517 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $68,923 worth of shares (13,515 units at $5.10), increasing direct ownership by 0.26% to 5,229,968 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $56,794 worth of shares (11,136 units at $5.10), increasing direct ownership by 0.21% to 5,216,453 units (SEC Form 4)
- Hudson Technologies Signs Joint Development Agreement with Icorium; Expands Commitment to Commercialize and Scale Patented Extractive Distillation Technology
- Large owner Hartree Partners, Lp bought $27,117 worth of shares (5,317 units at $5.10), increasing direct ownership by 0.10% to 5,205,317 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $553,047 worth of shares (100,612 units at $5.50), increasing direct ownership by 2% to 5,200,000 units (SEC Form 4)
- Hudson Technologies to Host Climate Week NYC 2026 Panel Discussion
- Large owner Hartree Partners, Lp bought $28,589 worth of shares (5,198 units at $5.50), increasing direct ownership by 0.10% to 5,099,388 units (SEC Form 4)
- SEC Form 10-Q filed by Hudson Technologies Inc.
Latest SNN
- SEC Form S-8 filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
- Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
- Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
- Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
- Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System